Saving sight, Saving lives – Aravind opens Asia’s first Genetic Testing Lab for Retinoblastoma

This summer, Aravind completed the final phase of development and installed the equipment in our Genetic Testing Lab for Retinoblastoma – the first of its kind in Asia. Retinoblastoma is a form of eye cancer that primarily affects children under age of five, robbing them of their sight and often their lives. In the US, over 90% of cases are cured. In India, more than 90% are fatal.

Over the last ten years, Aravind has become an internationally-recognized center of excellence for retinoblastoma research and treatment. Thank you to all our supporters who have helped establish the Genetic Testing Lab for Retinoblastoma. With all processes in house now, Aravind can offer affordable genetic testing to our patients. And, most importantly, with early diagnosis and treatment, save sight and lives!

We still need your support to pay for treatment of retinoblastoma patients – a full course of treatment costs $1000, well beyond the means of most Indian families. To learn more about how you can help and join Aravind’s Ring of Hope program, please click here.